Discover other firms ranked in Capital Markets: Equity (International Firms)

4
Band 4
A&O Shearman
4
A&O Shearman
24 Years Ranked

View profile
Paul Hastings LLP
4
Paul Hastings LLP
15 Years Ranked

View profile
Slaughter and May
4
Slaughter and May
15 Years Ranked

View profile
5
Band 5
Fangda Partners
5
Fangda Partners
6 Years Ranked

View profile
Morgan, Lewis & Bockius LLP
5
Morgan, Lewis & Bockius…
6 Years Ranked

View profile
Baker McKenzie
5
Baker McKenzie
9 Years Ranked

View profile

Chambers Review

Provided by Chambers

Capital Markets: Equity (International Firms) - China

5
Band 5

What the Team is Known For

Cooley fields a well-respected team that covers US and Hong Kong listings, private placements, and secondary and follow-on offerings. Its team acts for issuers, sponsors and underwriters and is particularly renowned for handling IPOs in the tech, healthtech and life sciences sectors.

Strengths

The team are well connected in China's tech ecosystem and are willing to find solutions in difficult and complex situations.

Cooley has a very strong Hong Kong capital market team. The lawyers have rich experience.

Cooley are very resourceful and knowledgeable in dealing with listing rules and deal execution. The senior partners are very hands-on, providing insightful suggestions.

Work Highlights

Cooley acted for Structure Therapeutics on its USD185.3 million IPO, including the full exercise of the underwriters’ option to purchase additional American depositary shares.

Notable practitioners

Hong Kong-based Will Cai heads the practice and is a key contact at the firm.